USPTO respinge procesul de brevet de medicamente pentru PTSD de la Lundbeck – Law360

By Adam Lidgett (February 2, 2024, 9:49 PM EST) — The U.S. Patent and Trademark Office is going for an early win in Virginia federal court where Danish drugmaker H. Lundbeck A/S is seeking to extend the life of a patent for a PTSD drug by three months, calling the case straightforward….